PL3193911T3 - Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A - Google Patents

Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A

Info

Publication number
PL3193911T3
PL3193911T3 PL15741222.2T PL15741222T PL3193911T3 PL 3193911 T3 PL3193911 T3 PL 3193911T3 PL 15741222 T PL15741222 T PL 15741222T PL 3193911 T3 PL3193911 T3 PL 3193911T3
Authority
PL
Poland
Prior art keywords
factor viii
treating hemophilia
improved factor
viii preparations
preparations
Prior art date
Application number
PL15741222.2T
Other languages
English (en)
Inventor
Stefan Schmidbauer
Hubert Metzner
Lars ROBBEL
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Publication of PL3193911T3 publication Critical patent/PL3193911T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15741222.2T 2014-07-25 2015-07-24 Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A PL3193911T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14178563 2014-07-25
PCT/EP2015/067014 WO2016012595A1 (en) 2014-07-25 2015-07-24 Improved factor viii preparations suitable for therapeutic use and processes to obtain these

Publications (1)

Publication Number Publication Date
PL3193911T3 true PL3193911T3 (pl) 2024-03-11

Family

ID=51257312

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15741222.2T PL3193911T3 (pl) 2014-07-25 2015-07-24 Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A

Country Status (6)

Country Link
US (1) US20170209546A1 (pl)
EP (1) EP3193911B1 (pl)
DK (1) DK3193911T5 (pl)
ES (1) ES2964658T3 (pl)
PL (1) PL3193911T3 (pl)
WO (1) WO2016012595A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018102743A1 (en) 2016-12-02 2018-06-07 Bioverativ Therapeutics Inc. Methods of treating hemophilic arthropathy using chimeric clotting factors
JP7763589B2 (ja) 2018-05-18 2025-11-04 バイオベラティブ セラピューティクス インコーポレイテッド 血友病ａを処置する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
CZ290342B6 (cs) * 1992-10-02 2002-07-17 Genetics Institute Inc. Kompozice stabilní při skladování, obsahující koagulační faktor VIII a neiontovou povrchově aktivní látku a způsob její výroby
US6221349B1 (en) * 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
AU2012318292B2 (en) * 2011-10-18 2015-08-20 Csl Limited Method for improving the stability of purified Factor VIII after reconstitution

Also Published As

Publication number Publication date
EP3193911B1 (en) 2023-09-06
DK3193911T5 (da) 2024-10-14
WO2016012595A1 (en) 2016-01-28
DK3193911T3 (da) 2023-11-27
ES2964658T3 (es) 2024-04-08
US20170209546A1 (en) 2017-07-27
EP3193911A1 (en) 2017-07-26

Similar Documents

Publication Publication Date Title
IL325256A (en) FAP-activated medical materials and related uses
GB2562968B (en) Simultaneous operations coordination and planning system
IL248937A0 (en) Biphasic cosmetics
PL3130671T3 (pl) Nowa deamidaza białkowa
IL251630A0 (en) Combined therapy for use in cancer treatment
GB201410816D0 (en) Therapeutic agents
IL252244A0 (en) Radioactive pharmaceutical complexes
GB201512044D0 (en) Application in German
GB201504784D0 (en) Complexes
GB201420761D0 (en) Dressing system
GB201410817D0 (en) Therapeutic agents
PL2987556T3 (pl) Maszyna rozdrabniająca
GB201420756D0 (en) Improvements in tissue processing
GB201410815D0 (en) Therapeutic agents
SI3169457T1 (sl) Stroj za obdelavo vsebnikov
GB201613876D0 (en) Complexes
GB2530598B (en) Arylsulphonamide arylpiperazines
GB201413942D0 (en) Peptides useful for treating cancer
PL3193911T3 (pl) Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A
GB201410452D0 (en) Smart material
GB201416493D0 (en) Polypeptides for use in therapy
GB201405898D0 (en) Dressing
GB201412857D0 (en) Treat bags
GB201405143D0 (en) Programming in computing
GB201505039D0 (en) Simultaneous operations coordination and planning system